Dr. Lal Pathlabs has reported results for fourth quarter and year ended March 31, 2022.
The company has reported a fall of 17.15% in its net profit at Rs 65.20 crore for the quarter under review as compared to Rs 78.70 crore for the same quarter in the previous year. However, total income of the company increased by 2.54% at Rs 427.80 crore for Q4FY22 as compared Rs 417.20 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 27.03% in its net profit at Rs 62.10 crore for the quarter under review as compared to Rs 85.10 crore for the same quarter in the previous year. However, total income of the company increased by 11.92% at Rs 497.50 crore for Q4FY22 as compared Rs 444.50 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a rise of 22.85% in its net profit at Rs 344.10 crore as compared to Rs 280.10 crore for the previous year. Total income of the company increased by 24.90% at Rs 1925.70 crore for year under review as compared to Rs 1541.80 crore for year ended March 31, 2021.
For the year ended March 31, 2022, on the consolidated basis, the company has reported a rise of 18.16% in its net profit at Rs 350.30 crore as compared to Rs 296.50 crore for the previous year. Total income of the company increased by 31.07% at Rs 2139.90 crore for year under review as compared to Rs 1632.60 crore for year ended March 31, 2021.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8094.85 |
| Max Healthcare Inst | 1012.35 |
| Narayana Hrudayalay | 1819.75 |
| Aster DM Healthcare | 742.40 |
| Global Health | 1200.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: